PROGRAM SELECTION & BENEFITS
JOIN OUR COMPASS AND GET ACCESS TO MORE THAN $1M IN PARTNER BENEFITS AND A PROGRAM OF ACCELERATION AND INCUBATION THAT CONNECTS YOU TO CLINICAL AND REGULATORY PATHWAY, REIMBURSEMENT, CAPITAL, AND MARKET ACCESS.
Connect from where ever you are located in the world and leverage the world's Expert MedTech Entrepreneurs as your partners to hit the road running in Europe. We measure ourselves by outcomes not just activities!
PAY FOR PLAY
3 month personalized Land and Expand Immersion Program & 6 month Incubation Coaching Program.
ENGAGE, & TRADE
Build your European GTM plan and fundraising roadmap with expert mentors and connect with the world's expert medtech entrepreneurs. Tap our global community of founders, angel investors, and venture capitalists.
DOWNLOAD OUR BROCHURE HERE
JOIN OUR MEETUP HERE
What We Do
House of MedTech 2021
The House of MedTech is inviting MedTech and digital healthcare pioneers to participate in a soft landing initiative that ultimately aims to make strategic business connections between scale-up companies, qualified Luxembourg research institutes, and European healthcare operators.
Supercharge your growth and ensure you hit the ground running with a 100% digital business partner that is the only English speaking hub, located in the hub of the European ecosystem, with a deeply experienced team of navigators that will help you to accelerate your regulatory pathway, reimbursement, increase brand awareness and market share, and access to non-dilutive and smart capital, in the European market.
A cohort of 10-20 companies is selected every six months to be incubated in the House of MedTech in our 9 month Luxembourg Calling Program.
3 months intensive + 6-month immersion
What's in it for your Company?
• Demonstrated export capability and the ability to comply with GDPR and data sovereignty.
• An established early-stage clinical study track record now seeking regulatory pathway for CE mark.
• MedTech and Digital Healthcare competencies that are uniquely differentiated and price competitive for the European market.
• A high-quality marketing, communications and dissemination program for market access.
Cohort companies are selected if they are ready to scale their companies into the European Union and have traction in their home market, with a sound demonstration of market demand from export markets. Successful applicants are likely to be research grant funded or sweat equity funded on the back of strong domestic clinical engagement or have already raised angel funding or previous venture capital investments from angels, foundations, family offices or VCs.
Cohort startups are paired with a Chief Navigator and go through a 3-month intensive land and expand program followed by a 6-month market and funding immersion. Companies are given a tailored program that aligns to their strategic objectives of connecting to market and capital and receives guided access to the R3I Ventures global community. Companies are connected at the highest levels of corporations to design strategic alliances, partnerships, and direct sales.
Chief Navigators work hand-in-hand to support Cohort companies with a personalized program designed in 6 phases:
FORMAT - 100% DIGITAL
THE HOUSE OF MEDTECH WAS PURPOSELY DESIGNED TO EMPOWER FOUNDERS IN A FRICTION FREE DIGITAL ECONOMY
(+ COVID19 PANDEMIC!)
Starting with our Spring 2021 Cohort, The House of MedTech has launched its inaugural Luxembourg calling program as a Digital Program permanently designed to enable Founders to thrive in a friction-free and digital economy. We invite Scaleups to participate remotely from all over the world.
These companies will continue to have the same high number of opportunities to network with investors, advisors, and to build community with fellow cohort members during this period than they would if they would permanently be based on the ground in Luxembourg. Package options are available for domestic hires, for colocation, to substantiate grant funding substance rules.
Founders have told us that they do not want to dilute for in-market immersion and expansion programs, which is why this program is equity-free as a Pay for Play Program. Founders First. Seek up to 100% reimbursement from your Government's Export Development Programs.
Frequently Asked Questions
What types of companies are you looking for? Can I still apply if my startup does not meet your exact requirements?
Primarily, we are looking for growth-stage MedTech startups from all around the world that have an interest in the European market using Luxembourg as an initial launchpad. We welcome and encourage all interested MedTech startups to apply. We will assess every application with inclusivity and independence. As signatories to the billion-dollar fund for women, we actively screen diverse founders into the portfolio.
Do you invest in the participating startups of this program?
This is an equity-free pay for play program. We do not promise investment in the participating startups of this program. This program is fundamentally a market access program and investment is not the primary objective. However, we do run an R3i Deal desk whose purpose it is to actively connect you to capital and to non-dilutive funding resources across the EU.
However, we understand that fund-raising is a long process and this could happen after the program ends. Therefore, we provide opportunities for our incubated companies to connect and network with key stakeholders in the government funding ecosystem, family offices, and the venture capital industry through our many events and activities. Each opportunity is a chance to participate in deeper due-diligence and to start building a longer-term relationship with potential funding partners and investors. A deal-desk run by the team at R3i Capital provides active venture funding acceleration and support.
Why are there program fees to participate?
Program fees help us cover the basic costs of running the program. This includes program costs such as platform and software subscriptions, navigator and program staff salaries, mentor fees, program, and founder marketing campaigns, digital events, digital learning on demand, and market access and business development costs.
Do I have to be present for the entire duration of the program?
Whilst we encourage startups and their founders to fully participate in the entire program, we understand that scaleup companies often have immediate business needs and obligations to address. It is a requirement that at least one (1) founder attends the program in full.
That being said, most masterclasses by mentors and events such as roundtables, panels, and speaker sessions will not be recorded in order to allow better interactions with the speakers and participants. If you are not present, you will most likely miss out on important content and have the ability to ask questions. Therefore, we highly encourage you to participate as fully as possible.
Are flights and accommodation provided for participants?
This is a no carbon incubator and accelerator program. Given COVID19, this program is designed to be entirely digital. From setting down roots in Luxembourg to opening your office and taking on your first clients/partners.
How many team members can participate in the program?
Typically, a startup would send one of the co-founders to attend the program.
The HOUSE OF MEDTECH operates on an entirely digital operating platform. We currently allow up to 5 (“five”) participants per startup. If you should require additional virtual desk space or would like to involve more participants from your startup, kindly let us know.
What does the curriculum look like? What does a typical day look like?
A workshop is held each month with a support assignment
Who are the Navigators who will work with me?
The HOUSE OF MEDTECH is a global community of responsible investors, serial entrepreneurs and founders, pioneers, thinkers and doers, logical pragmatists and intuitive visionaries, experts and generalists, and bright lights that, together, thrive on transformation rather than incremental change. Our global team combines seasoned track records and lessons learned, with passion, creativity, and dedication to help you to accelerate your products and services into the hands of your target partners and customers. We will provide targeted market and industry specific advice based on your business objectives and priorities. Navigators and mentors are selected in order to provide unique value and contribution to your specific business.
Should I apply again if I was previously rejected?
Absolutely. This program has been designed specifically to support early stage medtech companies in various funding and product development research stages. HOUSE OF MEDTECH will run 2 (“two”) cohorts each year, and even if you do not accepted to the current cohort, we encourage you to apply for the future opportunities.
What happens after the program?
Once you join any of the HOUSE OF MEDTECH programs, you will always be part of the HOUSE OF MEDTECH and R3i Ventures alumni. The relationships and connections built are designed to be the platform that lasts for a lifetime.
By accessing the domain of www.houseofmedtech.com and its associated web pages you agree to the following terms. If you do not agree to the following terms, please notice that you are not allowed to use the site. The contents of House of MedTech are managed by R3i Ventures Pte Limited and its web pages are Copyright © R3i Ventures Pte Limited. Any rights not expressly granted herein are reserved. Reproduction, transfer, distribution or storage of part or all of the contents in any form without the prior written permission of R3i Ventures Pte Limited is prohibited except in accordance with the terms outlined in this document. R3i Ventures Pte Limited provides access to this site free of charge to provide information about the House of MedTech. The sole authorised use of the site is to obtain information about the House of MedTech and any associated products/and/or services. No other use is permitted. R3i Ventures Pte Limited consents to you browsing these web pages on your computer or printing copies of extracts from these pages for your personal use only and not for redistribution unless consented to in writing by R3i Ventures Pte Limited. Individual documents in our web pages may be subject to additional terms indicated in those documents. The use of this site and the content therein, is permitted to private, non-commercial use. The use of press releases and other documents classified as public is permitted in public communications if the source for the information has been stated. R3i Ventures Pte Limited assumes no responsibility for the security of this site or your communications with the site. This site is offered AS IS and without warranties of any kind. R3i Ventures Pte Limited disclaims the implied warranties of merchantability and fitness for a specific purpose as well as title or non-infringement. We are not responsible for timeliness, accuracy, unavailability or interruptions in availability, viruses or other defects in the site or its contents. In no event shall R3i Ventures Pte Limited be responsible for any damages to users or their computer systems or otherwise, even if R3i Ventures Pte Limited has been informed of the possibility of such damages and without regard to negligence. For your convenience, R3i Ventures Pte Limited may include links to sites on the web that are owned or operated by third parties. By linking to such third-party site, you agree that R3i Ventures Pte Limited has no control over the content of that site and cannot assume any responsibility for material created or published by such third-party sites. Your access to this site should not be construed as granting, by implication, estoppel or otherwise, any license or right to use any marks or logos appearing on the site without the prior written consent of R3i Ventures Pte Limited or the third party owner thereof. Copyright © R3i Ventures Pte Limited 2020. All rights reserved.